References
- Huang WJ , ChenWW , ZhangX . Multiple sclerosis: pathology, diagnosis and treatments . Exp. Ther. Med.13 ( 6 ), 3163 – 3166 ( 2017 ).
- Gasperini C , CefaroLA , BorrielloG , TostoG , ProsperiniL , PozzilliC . Emerging oral drugs for multiple sclerosis . Exp. Opin. Emerg. Drugs13 ( 3 ), 465 – 477 ( 2008 ).
- Zhang GQ , MengY . Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider . Eur. Rev. Med. Pharmacol. Sci.19 ( 23 ), 4610 – 4620 ( 2015 ).
- Brola W , Mitosek-SzewczykK , OparaJ . Symptomatology and pathogenesis of different types of pain in multiple sclerosis . Neurol. Neurochir. Pol.48 ( 4 ), 272 – 279 ( 2014 ).
- Mazhari A . Multiple sclerosis-related pain syndromes: an imaging update . Curr. Pain Headache Rep.20 ( 12 ), 63 ( 2016 ).
- Khan N , SmithMT . Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models . Inflammopharmacology22 ( 1 ), 1 – 22 ( 2014 ).
- Danesh-Sani SA , RahimdoostA , SoltaniM , GhiyasiM , HaghdoostN , Sabzali-ZanjankhahnS . Clinical assessment of orofacial manifestations in 500 patients with multiple sclerosis . J. Oral Maxillofac. Surg.71 , 290 – 294 ( 2013 ).
- Chen DQ , DeSouzaDD , HayesDJ , DavisKD , O’ConnorP , HodaieM . Diffusivity signatures characterize trigeminal neuralgia associated with multiple sclerosis . Multiple Sclerosis J.22 , 51 – 63 ( 2016 ).
- Sahai-Srivastava S , WangSL , UgurluC , AmezcuaL . Headaches in multiple sclerosis: cross-sectional study of a multiethnic population . Clin. Neurol. Neurosurg.143 , 71 – 75 ( 2016 ).
- Moisset X , OuchchaneL , GuyN , BayleD , DallelR , ClavelouP . Migraine headaches and pain with neuropathic characteristics: comorbid conditions in patients with multiple sclerosis . Pain154 ( 12 ), 2691 – 2699 ( 2013 ).
- Solaro C , TrabuccoE , UccelliMM . Pain and multiple sclerosis: pathophysiology and treatment . Curr. Neurol. Neurosci. Rep.13 ( 1 ), 320 ( 2013 ).
- La Mantia L , ProneV . Headache in multiple sclerosis and autoimmune disorders . Neurol. Sci.36 ( Suppl. 1 ), 75 – 78 ( 2015 ).
- Truini A , BarbantiP , PozzilliC , CruccuG . A mechanism-based classification of pain in multiple sclerosis . J. Neurol.260 ( 2 ), 351 – 367 ( 2013 ).
- Swinnen C , LunskensS , DeryckO , CasselmanJ , VanopdenboschL . MRI characteristics of trigeminal nerve involvement in patients with multiple sclerosis . Mult. Scler. Relat. Disord.2 ( 3 ), 200 – 203 ( 2013 ).
- Truini A , ProsperiniL , CalistriVet al. A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis . Neurology86 , 2094 – 2099 ( 2016 ).
- Conti A , PontorieroA , IatìGet al. Frameless stereotactic radiosurgery for the treatment of multiple sclerosis-related trigeminal neuralgia . World Neurosurg.103 , 702 – 712 ( 2017 ).
- Bashir A , LiptonRB , AshinaS , AshinaM . Migraine and structural changes in the brain: a systematic review and meta-analysis . Neurology81 ( 14 ), 1260 – 1268 ( 2013 ).
- Pusic AD , MitchellHM , KunklerPE , KlauerN , KraigRP . Spreading depression transiently disrupts myelin via interferon-gamma signaling . Exp. Neurol.264 , 43 – 54 ( 2015 ).
- Merkler D , KlinkerF , JürgensTet al. Propagation of spreading depression inversely correlates with cortical myelin content . Ann. Neurol.66 ( 3 ), 355 – 365 ( 2009 ).
- Tabby D , MajeedMH , YoungmanB , WilcoxJ . Headache in multiple sclerosis: features and implications for disease management . Int. J. MS Care.15 ( 2 ), 73 – 80 ( 2013 ).
- Petit B , GiraudetF , BéchonCet al. Mice with a deletion of the major central myelin protein exhibit hypersensitivity to noxious thermal stimuli: involvement of central sensitization . Neurobiol. Dis.65 , 55 – 68 ( 2014 ).
- Grace PM , HutchinsonMR , MaierSF , WatkinsLR . Pathological pain and the neuroimmune interface . Nat. Rev. Immunol.14 ( 4 ), 217 – 231 ( 2014 ).
- Magni G , CerutiS . The purinergic system and glial cells: emerging costars in nociception . Biomed. Res. Int. 2014 , 495789 ( 2014 ).
- Ceruti S , VillaG , FumagalliMet al. Calcitonin gene-related peptide-mediated enhancement of purinergic neuron/glia communication by the algogenic factor bradykinin in mouse trigeminal ganglia from wild-type and R192Q Cav2.1 knock-in mice: implications for basic mechanisms of migraine pain . J. Neurosci.31 ( 10 ), 3638 – 3649 ( 2011 ).
- Liu FY , SunYN , WangFTet al. Activation of satellite glial cells in lumbar dorsal root ganglia contributes to neuropathic pain after spinal nerve ligation . Brain Res.1427 , 65 – 77 ( 2012 ).
- Magni G , MerliD , VerderioC , AbbracchioMP , CerutiS . P2Y2 receptor antagonists as anti-allodynic agents in acute and sub-chronic trigeminal sensitization: role of satellite glial cells . Glia63 ( 7 ), 1256 – 1269 ( 2015 ).
- Donegan M , KernisantM , CuaC , JasminL , OharaPT . Satellite glial cell proliferation in the trigeminal ganglia after chronic constriction injury of the infraorbital nerve . Glia61 ( 12 ), 2000 – 2008 ( 2013 ).
- Massier J , EitnerA , von BanchetGS , SchaibleHG . Effects of differently activated rodent macrophages on sensory neurons. Implications for arthritic pain . Arthritis Rheumatol.67 , 2263 – 2272 ( 2015 ).
- Franceschini A , VilottiS , FerrariMD , van den MaagdenbergAM , NistriA , FabbrettiE . TNFα levels and macrophages expression reflect an inflammatory potential of trigeminal ganglia in a mouse model of familial hemiplegic migraine . PLoS ONE8 ( 1 ), e52394 ( 2013 ).
- Correale J , FarezMF . The role of astrocytes in multiple sclerosis progression . Front. Neurol.6 , 180 ( 2015 ).
- Muzio L , MartinoG , FurlanR . Multifaceted aspects of inflammation in multiple sclerosis: the role of microglia . J. Neuroimmunol.191 ( 1–2 ), 39 – 44 ( 2007 ).
- Liddelow SA , GuttenplanKA , ClarkeLEet al. Neurotoxic reactive astrocytes are induced by activated microglia . Nature541 ( 7638 ), 481 – 487 ( 2017 ).
- Tsuda M , KogaK , ChenT , ZhuoM . Neuronal and microglial mechanisms for neuropathic pain in the spinal dorsal horn and anterior cingulate cortex . J. Neurochem.141 ( 4 ), 486 – 498 ( 2017 ).
- Mix E , Meyer-RieneckerH , HartungHP , ZettlUK . Animal models of multiple sclerosis – potentials and limitations . Prog. Neurobiol.92 ( 3 ), 386 – 404 ( 2010 ).
- Perera CJ , LeesJG , DuffySSet al. Effects of active immunisation with myelin basic protein and myelin-derived altered peptide ligand on pain hypersensitivity and neuroinflammation . J. Neuroimmunol.286 , 59 – 70 ( 2015 ).
- Zhu W , AcostaC , MacNeilBet al. Elevated expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the dorsal root ganglia and spinal cord in experimental autoimmune encephalomyelitis: implications in multiple sclerosis-induced neuropathic pain . Biomed. Res. Int. 2013 , 480702 ( 2013 ).
- Begum F , ZhuW , CortesC , MacNeilB , NamakaM . Elevation of tumor necrosis factor α in dorsal root ganglia and spinal cord is associated with neuroimmune modulation of pain in an animal model of multiple sclerosis . J. Neuroimmune Pharmacol.8 ( 3 ), 677 – 690 ( 2013 ).
- Warwick RA , LedgerwoodCJ , BrennerT , HananiM . Satellite glial cells in dorsal root ganglia are activated in experimental autoimmune encephalomyelitis . Neurosci. Lett.569 , 59 – 62 ( 2014 ).
- Duffy SS , PereraCJ , MakkerPGS , LeesJG , CarriveP , Moalem-TaylorG . Peripheral and central neuroinflammatory changes and pain behaviors in an animal model of multiple sclerosis . Front. Immunol.7 , 1 – 16 ( 2016 ).
- Khan N , WoodruffTM , SmithMT . Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods . Pharmacol. Biochem. Behav.126 , 13 – 27 ( 2014 ).
- Thorburn KC , PaylorJW , WebberCA , WinshipIR , KerrBJ . Facial hypersensitivity and trigeminal pathology in mice with experimental autoimmune encephalomyelitis . Pain157 ( 3 ), 627 – 642 ( 2016 ).
- Lee DW , BanquyX , KristiansenK , KaufmanY , BoggsJM , IsraelachviliJN . Lipid domains control myelin basic protein adsorption and membrane interactions between model myelin lipid bilayers . Proc. Natl Acad. Sci. USA111 ( 8 ), E768 – E775 ( 2014 ).
- Cermenati G , AudanoM , GiattiSet al. Lack of sterol regulatory element binding factor-1c imposes glial fatty acid utilization leading to peripheral neuropathy . Cell Metab.21 ( 4 ), 571 – 583 ( 2015 ).
- Magni G , CerutiS . P2Y purinergic receptors: new targets for analgesic and antimigraine drugs . Biochem. Pharmacol.85 ( 4 ), 466 – 477 ( 2013 ).
- Hunter SF , BowenJD , RederAT . The direct effects of fingolimod in the central nervous system: implications for relapsing multiple sclerosis . CNS Drugs30 ( 2 ), 135 – 147 ( 2016 ).
- Tamagnan G , TavaresA , BarretOet al. Brain distribution of BZM055, an analog of fingolimod (FTY720), in human . Mult. Scler.18 ( 10 ), S4 ( 2012 ).
- Rothhammer V , KenisonJE , TjonEet al. Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation . Proc. Natl Acad. Sci. USA114 ( 8 ), 2012 – 2017 ( 2017 ).
- Lee DH , SeubertS , HuhnKet al. Fingolimod effects in neuroinflammation: regulation of astroglial glutamate transporters? PLoS ONE 12 ( 3 ), e0171552 ( 2017 ).
- Sucksdorff M , RissanenE , TuiskuJet al. Evaluation of the effect of fingolimod treatment on microglial activation using serial PET imaging in multiple sclerosis . J. Nucl. Med.58 ( 10 ), 1646 – 1651 ( 2017 ).
- Garrido-Mesa N , ZarzueloA , GálvezJ . Minocycline: far beyond an antibiotic . Br. J. Pharmacol.169 ( 2 ), 337 – 352 ( 2013 ).
- Ji RR , BertaT , NedergaardM . Glia and pain: is chronic pain a gliopathy?Pain.154 ( Suppl. 1 ), S10 – S28 ( 2013 ).
- Piotrowska A , KwiatkowskiK , RojewskaEet al. Direct and indirect pharmacological modulation of CCL2/CCR2 pathway results in attenuation of neuropathic pain – in vivo and in vitro evidence . J. Neuroimmunol.297 , 9 – 19 ( 2016 ).
- Sun R , ZhaoZ , FengJet al. Glucocorticoid-potentiated spinal microglia activation contributes to preoperative anxiety-induced postoperative hyperalgesia . Mol. Neurobiol.54 ( 6 ), 4316 – 4328 ( 2017 ).
- Lopez-Diego RS , WeinerHL . Novel therapeutic strategies for multiple sclerosis – a multifaceted adversary . Nat. Rev. Drug Discov.7 ( 11 ), 909 – 925 ( 2008 ).
- Metz LM , LiDKB , TraboulseeALet al. Trial of minocycline in a clinically isolated syndrome of multiple sclerosis . N. Engl. J. Med.376 ( 22 ), 2122 – 2133 ( 2017 ).